Open an account

TELA Bio

TELA · NASDAQ

$1.09+$0.1197 (+12.34%)TodayMarket closed ·
Prev close $0.9703

About TELA

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company is headquartered in Malvern, Pennsylvania and currently employs 150 full-time employees. The company went IPO on 2019-11-08. The firm is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The firm's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

Employees
150
Headquarters
Malvern, Pennsylvania
Listed
Nov 8, 2019
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
telabio.com

TELA key statistics

Market cap
49.21M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
179.52K
Volume
173.26K
Open price
$0.95
High today
$1.14
Low today
$0.94
52 Week high
$1.56
52 Week low
$0.5011

TELA Bio (TELA) at a glance

As of Oct 20, 2026, TELA Bio (TELA) shares are priced at $1.09, giving the company a market cap of 49.21M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.94 and $1.14. The current price is 16.0% above the day's low and 4.4% below its high.

Volume so far is 173.26K shares, in line with the average of 179.52K shares a day.

Over the past year TELA Bio has ranged from $0.5011 to $1.56, and now sits 56% of the way up that range.

TELA Bio met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$0.20 per share against an estimate of -$0.1818.

The average analyst price target is $2.12, 95.0% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

80%of 5 analyst ratings say Buy
  • Buy80.0%
  • Hold20.0%
  • Sell0.0%
Price target · 8 analystsAvg $2.12
Low
$1.01
Now
$1.09
High
$3.15

TELA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 7.6% on average.

  1. Q3 FY24: reported -$0.42 per share against an estimate of -$0.4125
  2. Q4 FY24: reported -$0.23 per share against an estimate of -$0.2273
  3. Q1 FY25: reported -$0.25 per share against an estimate of -$0.1995
  4. Q2 FY25: reported -$0.22 per share against an estimate of -$0.1803
  5. Q3 FY25: reported -$0.19 per share against an estimate of -$0.203
  6. Q4 FY25: reported -$0.17 per share against an estimate of -$0.1863
  7. Q1 FY26: reported -$0.21 per share against an estimate of -$0.192
  8. Q2 FY26: reported -$0.20 per share against an estimate of -$0.1818

TELA news

  • Avi Kapoor

    5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

  • Press releaseGlobe Newswire

    After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Vandana Singh

    Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • Earnings Scheduled For May 8, 2025

  • 12 Health Care Stocks Moving In Friday's Intraday Session

Similar companies

Companies in the same industry as TELA Bio

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.